Turning clinical observations into real-world evidence (RWE) is influencing how therapies are validated and brought to ...

A systematic review and meta-analysis of 11 randomized controlled trials found that exercise during the post-weight-loss ...

An evidence-based website could help patients better understand these treatments ...

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, ...

The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...

For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...

Sleep affects nearly every chronic condition healthcare wants to manage. here's why cannabinoids like CBN are emerging as ...

It’s just in your head.” When work deadlines pile up, financial worries linger or an unexpected public speaking obligation ...

Landau, MD, discussed promising results of CAR T-cell therapy in light chain amyloidosis and the challenge of developing ...

Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

Vivani CEO Adam Mendelsohn, Ph.D., stated, “HREC approval to initiate SLIM-1 in Australia marks an important moment for our Company, clearing the way for near-term, mid-2026, initiation. We are eager ...